Here, we assessed the associations of the newly developed 313-SNP breast cancer PRS and 147-SNP prostate cancer PRS derived using population-based data, with breast and prostate cancer risks, respectively, for male BRCA1 and BRCA2 carriers. Here, BRCA2 is linked to Familial prostate cancer.